Paper36988258
TBK1 promotes thyroid cancer progress by activating the PI3K/Akt/mTOR signaling pathway.
Jiang Q and 3 others. Immun Inflamm Dis, 2023. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. TBK1 promotes thyroid cancer progress by activating the PI3K/Akt/mTOR signaling pathway. Papers, record 36988258. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36988258
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Proto-Oncogene Proteins c-akt | Major topic |
| Thyroid Neoplasms | Major topic |
| Humans | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Phosphatidylinositol 3-Kinases | |
| Protein Serine-Threonine Kinases | |
| RNA, Small Interfering | |
| Signal Transduction | |
| TOR Serine-Threonine Kinases |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36988258 | TBK1 promotes thyroid cancer progress by activating the PI3K/Akt/mTOR signaling pathway. | Immun Inflamm Dis | 2023 | https://conductscience.org/library/papers/36988258 | PubMed |
| 2 | 29677534 | Punicalagin induces senescent growth arrest in human papillary thyroid carcinoma BCPAP cells via NF-κB signaling pathway. | Biomed Pharmacother | 2018 | https://conductscience.org/library/papers/29677534 | PubMed |
| 3 | 10990461 | Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. | EMBO J | 2000 | https://conductscience.org/library/papers/10990461 | PubMed |
| 4 | 28819387 | TBK1 Promote Bladder Cancer Cell Proliferation and Migration via Akt Signaling. | J Cancer | 2017 | https://conductscience.org/library/papers/28819387 | PubMed |
| 5 | 24662939 | The Role of STAT3 in Thyroid Cancer. | Cancers (Basel) | 2014 | https://conductscience.org/library/papers/24662939 | PubMed |
| 6 | 24027431 | TBK1 regulates prostate cancer dormancy through mTOR inhibition. | Neoplasia | 2013 | https://conductscience.org/library/papers/24027431 | PubMed |
| 7 | 30463570 | LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling. | J Exp Clin Cancer Res | 2018 | https://conductscience.org/library/papers/30463570 | PubMed |
| 8 | 33883901 | Actin-Like Protein 8 Promotes the Progression of Triple-Negative Breast Cancer via Activating PI3K/AKT/mTOR Pathway. | Onco Targets Ther | 2021 | https://conductscience.org/library/papers/33883901 | PubMed |
| 9 | 30207593 | Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2018 | https://conductscience.org/library/papers/30207593 | PubMed |
| 10 | 30932713 | TANK-binding kinase 1 as a novel therapeutic target for viral diseases. | Expert Opin Ther Targets | 2019 | https://conductscience.org/library/papers/30932713 | PubMed |
| 11 | 29559975 | TANK-Binding Kinase 1-Dependent Responses in Health and Autoimmunity. | Front Immunol | 2018 | https://conductscience.org/library/papers/29559975 | PubMed |
| 12 | 31238008 | Two distinct E3 ligases, SCFFBXL19 and HECW1, degrade thyroid transcription factor 1 in normal thyroid epithelial and follicular thyroid carcinoma cells, respectively. | FASEB J | 2019 | https://conductscience.org/library/papers/31238008 | PubMed |
| 13 | 24062311 | Loss of TBK1 induces epithelial-mesenchymal transition in the breast cancer cells by ERα downregulation. | Cancer Res | 2013 | https://conductscience.org/library/papers/24062311 | PubMed |
| 14 | 23602735 | Synergistic inhibition of thyroid cancer by suppressing MAPK/PI3K/AKT pathways. | J Surg Res | 2013 | https://conductscience.org/library/papers/23602735 | PubMed |
| 15 | 26607461 | BX795, a TBK1 inhibitor, exhibits antitumor activity in human oral squamous cell carcinoma through apoptosis induction and mitotic phase arrest. | Eur J Pharmacol | 2015 | https://conductscience.org/library/papers/26607461 | PubMed |
| 16 | 30938713 | Axl-mediated activation of TBK1 drives epithelial plasticity in pancreatic cancer. | JCI Insight | 2019 | https://conductscience.org/library/papers/30938713 | PubMed |
| 17 | 33310066 | Tank Binding Kinase 1 modulates spindle assembly checkpoint components to regulate mitosis in breast and lung cancer cells. | Biochim Biophys Acta Mol Cell Res | 2021 | https://conductscience.org/library/papers/33310066 | PubMed |
| 18 | 34184083 | M2‑like tumour‑associated macrophage‑secreted IGF promotes thyroid cancer stemness and metastasis by activating the PI3K/AKT/mTOR pathway. | Mol Med Rep | 2021 | https://conductscience.org/library/papers/34184083 | PubMed |
| 19 | 28716898 | TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer. | Cancer Res | 2017 | https://conductscience.org/library/papers/28716898 | PubMed |
| 20 | 34336120 | lncRNA NONHSAT069381 and NONHSAT140844 Increase in Aging Human Blood, Regulating Cardiomyocyte Apoptosis. | Oxid Med Cell Longev | 2021 | https://conductscience.org/library/papers/34336120 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42432576 | CXCR6 and its correlated G protein-coupled receptors and PI3K-AKT pathways were associated with the progression of thyroid cancer. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42432576 | PubMed |
| 42305478 | Periostin promotes papillary thyroid carcinoma progression by modulating mTOR/AKT pathway. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42305478 | PubMed |
| 41347830 | Saikosaponin D overcomes gemcitabine resistance in pancreatic cancer via AKT/mTOR pathway inhibition and synergistic induction of apoptosis and autophagy. | Oncol Rep | 2026 | https://conductscience.org/library/papers/41347830 | PubMed |
| 41281490 | Myc-associated zinc finger protein drives colorectal cancer metastasis through activating ubiquitin like with ring finger protein one. | World J Gastrointest Oncol | 2025 | https://conductscience.org/library/papers/41281490 | PubMed |
| 41079430 | TBK1 mutation and its role in frontotemporal dementia and amyotrophic lateral sclerosis in Brazilian families. | Dement Neuropsychol | 2025 | https://conductscience.org/library/papers/41079430 | PubMed |
| 40722651 | Molecular Markers for Thyroid Cancer Diagnosis: Insights from MAPK Pathway Gene Expression Analysis. | Biomedicines | 2025 | https://conductscience.org/library/papers/40722651 | PubMed |
| 40552073 | HIF1A acts as target of XiHuang Pill in the treatment of papillary thyroid cancer by regulating dedifferentiation. | Front Chem | 2025 | https://conductscience.org/library/papers/40552073 | PubMed |
| 39934163 | BBOX1 restrains TBK1-mTORC1 oncogenic signaling in clear cell renal cell carcinoma. | Nat Commun | 2025 | https://conductscience.org/library/papers/39934163 | PubMed |
| 39833432 | Investigation of Scutellaria Barbata's immunological mechanism against thyroid cancer using network pharmacology and experimental validation. | Sci Rep | 2025 | https://conductscience.org/library/papers/39833432 | PubMed |
| 39744441 | TBK1 inhibitor amlexanox exerts anti-cancer effects against endometrial cancer by regulating AKT/NF-κB signaling. | Int J Biol Sci | 2025 | https://conductscience.org/library/papers/39744441 | PubMed |
| 39737135 | Midkine promotes thyroid cancer cell migration and invasion by activating the phosphatidylinositol 3 kinase/protein kinase B/mammalian target of rapamycin pathway. | Cytojournal | 2024 | https://conductscience.org/library/papers/39737135 | PubMed |
| 39532991 | Molecular mechanisms of MAZ targeting up-regulation of NDUFS3 expression to promote malignant progression in melanoma. | Commun Biol | 2024 | https://conductscience.org/library/papers/39532991 | PubMed |
| 39289178 | In Silico Insights: QSAR Modeling of TBK1 Kinase Inhibitors for Enhanced Drug Discovery. | J Chem Inf Model | 2024 | https://conductscience.org/library/papers/39289178 | PubMed |
| 39093515 | miR-144-3p Targets GABRB2 to Suppress Thyroid Cancer Progression In Vitro. | Cell Biochem Biophys | 2024 | https://conductscience.org/library/papers/39093515 | PubMed |
| 39061024 | MARCH1 negatively regulates TBK1-mTOR signaling pathway by ubiquitinating TBK1. | BMC Cancer | 2024 | https://conductscience.org/library/papers/39061024 | PubMed |
| 36988258 | TBK1 promotes thyroid cancer progress by activating the PI3K/Akt/mTOR signaling pathway. | Immun Inflamm Dis | 2023 | https://conductscience.org/library/papers/36988258 | PubMed |
Genes22
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36988258
GET https://conductscience.org/api/papers/v1/36988258/references?page=2